+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Typhoid Fever Vaccines Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Vaccine Type; Route of administration, and Geography.

  • ID: 5188118
  • Report
  • October 2020
  • Region: Global
  • 141 pages
  • The Insight Partners

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • BHARAT BIOTECH
  • BIO-MED
  • GlaxoSmithKline plc.
  • Paxvax Inc.
  • Prokarium Ltd.
  • PT Bio Farma

According to the new market research study on “Typhoid fever vaccines Market to 2027 Global Analysis and Forecast by vaccine type and route of administration” the market is expected to reach US$ 525.32 million by 2027 from US$ 262.81 million in 2019. The market is estimated to grow with a CAGR of 9.3% from 2020 to 2027. The report highlights trends prevailing in the market, and drivers and hindrances pertaining to the market growth.

Based on vaccine type, the market is segmented in to live attenuated vaccine, capsular polysaccharide vaccines, conjugate vaccine, and others. In 2019, the capsular polysaccharide vaccines segment accounted for the highest share of the market. Growth of this segment is attributed to the effectiveness associated with in preventing infections and increasing patient pool across the globe. The Live Attenuated Vaccine segment is likely to register highest CAGR in the global Typhoid fever vaccines market during the forecast period.

Global Typhoid fever vaccines Market, based on route of administration, the Typhoid fever vaccines market is segmented into oral and injections. The injectable segment held the largest share of the market in 2019, whereas the oral segment is anticipated to register the highest CAGR of 10.1% in the market during the forecast period.

COVID-19 pandemic has become the most significant challenge across the world. This challenge will be frightening especially in developing countries across the globe as it will lead to reducing imports due to disruptions in global trade, which further increases the shortages of medical supplies and other goods, resulting in a considerable price increase. The World Health Organization and UNICEF warned an alarming decline in the number of children receiving life-saving vaccines around the world. This is due to disruptions in the delivery and uptake of immunization services caused by the COVID-19 pandemic. In 2019, UNICEF procured an estimated 2.43 billion doses of vaccines to around 100 countries to reach around 45% of the world’s children below the 5-year-old age group.

Shanghai Institute of Biological Products Co. Ltd., Bharat Biotech, Sanofi, GlaxoSmithKline, Paxvax Inc. PT Bio Farma, BIO-MED, Prokarium Ltd.Scandinavian Biopharma are among the leading companies operating in the Typhoid fever vaccines market.

The Report Segments Global Typhoid Fever Vaccines Market as Follows:

By Type

  • Live Attenuated Vaccine
  • Capsular Polysaccharide Vaccines
  • Conjugate Vaccine
  • Others

By Route of Administration

  • Oral
  • Injections

By Geography

North America

  • US
  • Canada
  • Mexico

Europe

  • France
  • Germany
  • Italy
  • UK
  • Spain
  • Rest of the Europe

Asia Pacific (APAC)

  • China
  • India
  • South Korea
  • Japan
  • Australia
  • Rest of Asia Pacific

Middle East & Africa (MEA)

  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa

South America (SAM)

  • Brazil
  • Argentina
  • Rest of South America

Reasons to Buy

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the typhoid fever vaccines market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global typhoid fever vaccines market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • BHARAT BIOTECH
  • BIO-MED
  • GlaxoSmithKline plc.
  • Paxvax Inc.
  • Prokarium Ltd.
  • PT Bio Farma

1. Introduction
1.1 Scope of the Study
1.2 Report Guidance
1.3 Market Segmentation
1.3.1 Typhoid Fever Vaccines Market - By Vaccine Type
1.3.2 Typhoid Fever Vaccines Market - By Route of Administration
1.3.3 Global Typhoid Fever Vaccines Market - By Geography

2. Typhoid Fever Vaccines Market - Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Global Typhoid Fever Vaccines- Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America - PEST Analysis
4.2.2 Europe - PEST Analysis
4.2.3 Asia Pacific - PEST Analysis
4.2.4 Middle East and Africa (MEA) - PEST Analysis
4.2.5 South and Central America (SCAM) - PEST Analysis
4.3 Expert Opinions

5. Typhoid Fever Vaccines Market- Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Growing Number of Patients Suffering with Typhoid
5.1.2 Organizations Supporting Typhoid Immunizations
5.2 Market Restraint
5.2.1 Risk of Side-Effects Associated with Typhoid Fever Vaccines
5.3 Market Opportunity
5.3.1 Outsourcing Pharmaceutical Research
5.4 Future Trend
5.4.1 Development of Innovative and Potent Vaccine Candidates
5.5 Impact Analysis

6. Typhoid Fever Vaccines Market - Global Analysis
6.1 Global Typhoid Fever Vaccines Marker Revenue Forecast And Analysis
6.2 Global Typhoid Fever Vaccines Market, By Geography - Forecast And Analysis
6.3 Market Positioning of Key Players

7. Typhoid Fever Vaccines Market - By Vaccine Type
7.1 Overview
7.2 Typhoid Fever Vaccines Market, by Vaccine Type, 2019 and 2027 (%)
7.3 Live Attenuated Vaccine
7.3.1 Overview
7.3.2 Live Attenuated Vaccine : Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
7.4 Capsular Polysaccharide Vaccines
7.4.1 Overview
7.4.2 Capsular Polysaccharide Vaccines: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
7.5 Conjugate Vaccine
7.5.1 Overview
7.5.2 Conjugate Vaccine: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (US$ Million)

8. Typhoid Fever Vaccines Market Analysis - By Route of Administration
8.1 Overview
8.2 Typhoid Fever Vaccines Market Revenue Share, by Route of Administration (2019 and 2027)
8.2.1 Oral
8.2.1.1 Overview
8.2.2 Oral: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
8.3 Injectable
8.3.1 Overview
8.3.2 Injectable: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (US$ Million)

9. Typhoid Fever Vaccines Market Analysis And Forecast To 2027 - Geographical Analysis
9.1 North America: Typhoid Fever Vaccines Market
9.1.1 Overview
9.1.2 North America: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
9.1.3 North America: Typhoid Fever Vaccines Market, by Vaccine Type, 2018-2027 (USD Million)
9.1.4 North America: Typhoid Fever Vaccines Market, by Route of Administration, 2018-2027 (USD Million)
9.1.5 North America: Typhoid Fever Vaccines Market, by Country, 2019 & 2027 (%)
9.1.6 US: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
9.1.6.1 US: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
9.1.6.2 US: Typhoid Fever Vaccines Market, by Vaccine Type, 2018-2027 (USD Million)
9.1.6.3 US: Typhoid Fever Vaccines Market, by Route of Administration 2018-2027 (USD Million)
9.1.7 Canada: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
9.1.7.1 Canada: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
9.1.7.2 Canada: Typhoid Fever Vaccines Market, by Vaccine Type, 2018-2027 (USD Million)
9.1.7.3 Canada: Typhoid Fever Vaccines Market, by Route of Administration 2018-2027 (USD Million)
9.1.8 Mexico: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
9.1.8.1 Mexico: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
9.1.8.2 Mexico: Typhoid Fever Vaccines Market, by Vaccine Type, 2018-2027 (USD Million)
9.1.8.3 Mexico: Typhoid Fever Vaccines Market, by Route of Administration 2018-2027 (USD Million)
9.2 Europe: Typhoid Fever Vaccines Market
9.2.1 Overview
9.2.2 Europe: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
9.2.3 Europe: Typhoid Fever Vaccines Market, by Vaccine Type, 2018-2027 (USD Million)
9.2.4 Europe: Typhoid Fever Vaccines Market, by Route of Administration 2018-2027 (USD Million)
9.2.5 Europe: Typhoid Fever Vaccines Market, by Country, 2018 & 2027 (%)
9.2.6 Germany: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
9.2.6.1 Germany: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
9.2.6.2 Germany: Typhoid Fever Vaccines Market, by Vaccine Type, 2018-2027 (USD Million)
9.2.6.3 Germany: Typhoid Fever Vaccines Market, by Route of Administration 2018-2027 (USD Million)
9.2.7 UK: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
9.2.7.1 UK: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
9.2.7.2 UK: Typhoid Fever Vaccines Market, by Vaccine Type, 2018-2027 (USD Million)
9.2.7.3 UK: Typhoid Fever Vaccines Market, by Route of Administration 2018-2027 (USD Million)
9.2.8 France: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
9.2.8.1 France: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
9.2.8.2 France: Typhoid Fever Vaccines Market, by Vaccine Type, 2018-2027 (USD Million)
9.2.8.3 France: Typhoid Fever Vaccines Market, by Route of Administration 2018-2027 (USD Million)
9.2.9 Spain: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
9.2.9.1 Spain: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
9.2.9.2 Spain: Typhoid Fever Vaccines Market, by Vaccine Type, 2018-2027 (USD Million)
9.2.9.3 Spain: Typhoid Fever Vaccines Market, by Route of Administration 2018-2027 (USD Million)
9.2.10 Italy: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
9.2.10.1 Italy: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
9.2.10.2 Italy: Typhoid Fever Vaccines Market, by Vaccine Type, 2018-2027 (USD Million)
9.2.10.3 Italy: Typhoid Fever Vaccines Market, by Route of Administration 2018-2027 (USD Million)
9.2.11 Rest of Europe: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
9.2.11.1 Rest of Europe: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
9.2.11.2 Rest of Europe: Typhoid Fever Vaccines Market, by Vaccine Type, 2018-2027 (USD Million)
9.2.11.3 Rest of Europe: Typhoid Fever Vaccines Market, by Route of Administration 2018-2027 (USD Million)
9.3 Asia Pacific: Typhoid Fever Vaccines Market
9.3.1 Overview
9.3.2 Asia Pacific: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
9.3.3 Asia Pacific: Typhoid Fever Vaccines Market, by Vaccine Type, 2018-2027 (USD Million)
9.3.4 Asia Pacific: Typhoid Fever Vaccines Market, by Route of Administration 2018-2027 (USD Million)
9.3.5 Asia Pacific: Typhoid Fever Vaccines Market, by Country, 2018 & 2027 (%)
9.3.6 China: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
9.3.6.1 China: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
9.3.6.2 China: Typhoid Fever Vaccines Market, by Vaccine Type, 2018-2027 (USD Million)
9.3.6.3 China: Typhoid Fever Vaccines Market, by Route of Administration 2018-2027 (USD Million)
9.3.7 Japan: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
9.3.7.1 Japan: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
9.3.7.2 Japan: Typhoid Fever Vaccines Market, by Vaccine Type, 2018-2027 (USD Million)
9.3.7.3 Japan: Typhoid Fever Vaccines Market, by Route of Administration 2018-2027 (USD Million)
9.3.8 India: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
9.3.8.1 India: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
9.3.8.2 India: Typhoid Fever Vaccines Market, by Vaccine Type, 2018-2027 (USD Million)
9.3.8.3 India: Typhoid Fever Vaccines Market, by Route of Administration 2018-2027 (USD Million)
9.3.9 South Korea: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
9.3.9.1 South Korea: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
9.3.9.2 South Korea: Typhoid Fever Vaccines Market, by Vaccine Type, 2018-2027 (USD Million)
9.3.9.3 South Korea: Typhoid Fever Vaccines Market, by Route of Administration 2018-2027 (USD Million)
9.3.10 Australia: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
9.3.10.1 Australia: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
9.3.10.2 Australia: Typhoid Fever Vaccines Market, by Vaccine Type, 2018-2027 (USD Million)
9.3.10.3 Australia: Typhoid Fever Vaccines Market, by Route of Administration 2018-2027 (USD Million)
9.3.11 Rest of Asia-Pacific: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
9.3.11.1 Rest of Asia-Pacific: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
9.3.11.2 Rest of Asia-Pacific: Typhoid Fever Vaccines Market, by Vaccine Type, 2018-2027 (USD Million)
9.3.11.3 Rest of Asia-Pacific: Typhoid Fever Vaccines Market, by Route of Administration 2018-2027 (USD Million)
9.4 Middle East and Africa: Typhoid Fever Vaccines Market
9.4.1 Overview
9.4.2 Middle East and Africa: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
9.4.3 Middle East and Africa: Typhoid Fever Vaccines Market, by Vaccine Type- Revenue and Forecast to 2027 (USD Million)
9.4.4 Middle East and Africa: Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
9.4.5 Middle East & Africa: Typhoid Fever Vaccines Market, by Country, 2019 & 2027 (%)
9.4.6 Saudi Arabia: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
9.4.6.1 Saudi Arabia: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
9.4.6.2 Saudi Arabia: Typhoid Fever Vaccines Market, by Vaccine Type- Revenue and Forecast to 2027 (USD Million)
9.4.6.3 Saudi Arabia: Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
9.4.7 UAE: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
9.4.7.1 UAE: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
9.4.7.2 UAE: Typhoid Fever Vaccines Market, by Vaccine Type- Revenue and Forecast to 2027 (USD Million)
9.4.7.3 UAE: Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
9.4.8 South Africa: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
9.4.8.1 South Africa: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
9.4.8.2 South Africa: Typhoid Fever Vaccines Market, by Vaccine Type- Revenue and Forecast to 2027 (USD Million)
9.4.8.3 South Africa: Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
9.4.9 Rest of Middle East & Africa (MEA): Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
9.4.9.1 Rest of MEA: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
9.4.9.2 Rest of MEA: Typhoid Fever Vaccines Market, by Vaccine Type- Revenue and Forecast to 2027 (USD Million)
9.4.9.3 Rest of MEA: Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
9.5 South & Central America: Typhoid Fever Vaccines Market
9.5.1 Overview
9.5.2 South & Central America: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
9.5.3 South & Central America: Typhoid Fever Vaccines Market, by Vaccine Type- Revenue and Forecast to 2027 (USD Million)
9.5.4 South & Central America: Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
9.5.5 South & Central America: Typhoid Fever Vaccines Market, by Country, 2019 & 2027 (%)
9.5.6 Brazil: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
9.5.6.1 Brazil: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
9.5.6.2 Brazil: Typhoid Fever Vaccines Market, by Vaccine Type- Revenue and Forecast to 2027 (USD Million)
9.5.6.3 Brazil: Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
9.5.7 Argentina: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
9.5.7.1 Argentina: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
9.5.7.2 Argentina: Typhoid Fever Vaccines Market, by Vaccine Type- Revenue and Forecast to 2027 (USD Million)
9.5.7.3 Argentina: Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
9.5.8 Rest of SCAM: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
9.5.8.1 Rest of SCAM: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
9.5.8.2 Rest of SCAM: Typhoid Fever Vaccines Market, by Vaccine Type- Revenue and Forecast to 2027 (USD Million)
9.5.8.3 Rest of SCAM: Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)

10. Impact of COVID-19 Pandemic on Global Typhoid Fever Vaccines Market
10.1 North America: Impact Assessment of COVID-19 Pandemic
10.2 Europe: Impact Assessment of COVID-19 Pandemic
10.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
10.4 Rest of the World: Impact Assessment of COVID-19 Pandemic

11. Industry Landscape
11.1 Overview
11.2 Growth Strategies Done by the Companies in the Market, (%)
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic Developments
11.4.1 Overview

12. Company Profiles
12.1 Shanghai institute of biological products co., ltd.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Paxvax Inc.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 PT Bio Farma
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 BIO-MED
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 BHARAT BIOTECH
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Sanofi
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 GlaxoSmithKline plc.
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Prokarium Ltd.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 SCANDINAVIAN BIOPHARMA
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments

13. Appendix
13.1 About the Publisher
13.2 Glossary of Terms

List of Tables
Table 1. North America Typhoid Fever Vaccines Market, by Vaccine Type - Revenue and Forecast to 2027 (USD Million)
Table 2. North America Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 3. US Typhoid Fever Vaccines Market, by Vaccine Type - Revenue and Forecast to 2027 (USD Million)
Table 4. US Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 5. Canada Typhoid Fever Vaccines Market, by Vaccine Type - Revenue and Forecast to 2027 (USD Million)
Table 6. Canada Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 7. Mexico Typhoid Fever Vaccines Market, by Vaccine Type - Revenue and Forecast to 2027 (USD Million)
Table 8. Mexico Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 9. Europe Typhoid Fever Vaccines Market, by Vaccine Type - Revenue and Forecast to 2027 (USD Million)
Table 10. Europe Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 11. Germany Typhoid Fever Vaccines Market, by Vaccine Type - Revenue and Forecast to 2027 (USD Million)
Table 12. Germany Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 13. UK Typhoid Fever Vaccines Market, by Vaccine Type - Revenue and Forecast to 2027 (USD Million)
Table 14. UK Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 15. France Typhoid Fever Vaccines Market, by Vaccine Type - Revenue and Forecast to 2027 (USD Million)
Table 16. France Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 17. Spain Typhoid Fever Vaccines Market, by Vaccine Type - Revenue and Forecast to 2027 (USD Million)
Table 18. Spain Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 19. Italy Typhoid Fever Vaccines Market, by Vaccine Type - Revenue and Forecast to 2027 (USD Million)
Table 20. Italy Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 21. Rest of Europe Typhoid Fever Vaccines Market, by Vaccine Type - Revenue and Forecast to 2027 (USD Million)
Table 22. Rest of Europe Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 23. Asia Pacific Typhoid Fever Vaccines Market, by Vaccine Type - Revenue and Forecast to 2027 (USD Million)
Table 24. Asia Pacific Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 25. China Typhoid Fever Vaccines Market, by Vaccine Type - Revenue and Forecast to 2027 (USD Million)
Table 26. China Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 27. Japan Typhoid Fever Vaccines Market, by Vaccine Type - Revenue and Forecast to 2027 (USD Million)
Table 28. Japan Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 29. India Typhoid Fever Vaccines Market, by Vaccine Type - Revenue and Forecast to 2027 (USD Million)
Table 30. India Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 31. South Korea Typhoid Fever Vaccines Market, by Vaccine Type - Revenue and Forecast to 2027 (USD Million)
Table 32. South Korea Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 33. Australia Typhoid Fever Vaccines Market, by Vaccine Type - Revenue and Forecast to 2027 (USD Million)
Table 34. Australia Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 35. Rest of Asia -Pacific Typhoid Fever Vaccines Market, by Vaccine Type - Revenue and Forecast to 2027 (USD Million)
Table 36. Rest of Asia -Pacific Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 37. Middle East & Africa: Typhoid Fever Vaccines Market, by Vaccine Type - Revenue and Forecast to 2027 (USD Million)
Table 38. Middle East and Africa: Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 39. Saudi Arabia: Typhoid Fever Vaccines Market, by Vaccine Type - Revenue and Forecast to 2027 (USD Million)
Table 40. Saudi Arabia: Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 41. UAE: Typhoid Fever Vaccines Market, by Vaccine Type - Revenue and Forecast to 2027 (USD Million)
Table 42. UAE: Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 43. South Africa: Typhoid Fever Vaccines Market, by Vaccine Type - Revenue and Forecast to 2027 (USD Million)
Table 44. South Africa: Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 45. Rest of MEA: Typhoid Fever Vaccines Market, by Vaccine Type - Revenue and Forecast to 2027 (USD Million)
Table 46. Rest of MEA: Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 47. South & Central America: Typhoid Fever Vaccines Market, by Vaccine Type - Revenue and Forecast to 2027 (USD Million)
Table 48. South & Central America: Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 49. Brazil: Typhoid Fever Vaccines Market, by Vaccine Type - Revenue and Forecast to 2027 (USD Million)
Table 50. Brazil: Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 51. Argentina: Typhoid Fever Vaccines Market, by Vaccine Type - Revenue and Forecast to 2027 (USD Million)
Table 52. Argentina: Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 53. Rest of SCAM: Typhoid Fever Vaccines Market, by Vaccine Type - Revenue and Forecast to 2027 (USD Million)
Table 54. Rest of SCAM: Typhoid Fever Vaccines Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 55. Organic Developments Done By Companies
Table 56. Inorganic Developments Done By Companies
Table 57. Glossary of Terms, Typhoid Fever Vaccines Market

List of Figures
Figure 1. Typhoid Fever Vaccines Market Segmentation
Figure 2. Typhoid Fever Vaccines Market - by Geography
Figure 3. Typhoid Fever Vaccines Market Overview
Figure 4. Live Attenuated Vaccine Segment Witness Fastest Growth
Figure 5. Asia Pacific to show Significant Growth during Forecast Period
Figure 6. Typhoid Fever Vaccines Market, by Geography (US$ Million)
Figure 7. Global Typhoid Fever Vaccines Market - Leading Country Markets (US$ Million)
Figure 8. Global Typhoid Fever Vaccines Market, Industry Landscape
Figure 9. North America PEST Analysis
Figure 10. Europe PEST Analysis
Figure 11. Asia Pacific PEST Analysis
Figure 12. Middle East and Africa (MEA) PEST Analysis
Figure 13. South and Central America (SCAM) PEST Analysis
Figure 14. Typhoid Fever Vaccines Market Impact Analysis of Drivers and Restraint
Figure 15. Global Typhoid Fever Vaccines Market - Revenue Forecast and Analysis - 2019- 2027
Figure 16. Global Typhoid Fever Vaccines Market - by Geography Forecast and Analysis - 2019- 2027
Figure 17. Market Positioning of Key Players in Global Typhoid Fever Vaccines Market
Figure 18. Typhoid Fever Vaccines Market, by Vaccine Type, 2019 and 2027 (%)
Figure 19. Live Attenuated Vaccine : Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
Figure 20. Capsular Polysaccharide Vaccines: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
Figure 21. Conjugate Vaccine: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
Figure 22. Others: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
Figure 23. Typhoid Fever Vaccines Market Revenue Share, by Route of Administration (2019 and 2027)
Figure 24. Oral: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
Figure 25. Injectable: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (US$ Million)
Figure 26. North America: Typhoid Fever Vaccines Market, by Key Country - Revenue (2019) (USD Million)
Figure 27. North America Typhoid Fever Vaccines Market Revenue and Forecast to 2027 (USD Million)
Figure 28. North America: Typhoid Fever Vaccines Market, by Country, 2019 & 2027 (%)
Figure 29. US: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
Figure 30. Canada: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
Figure 31. Mexico: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
Figure 32. Europe: Typhoid Fever Vaccines Market, by Key Country - Revenue (2019) (USD Million)
Figure 33. Europe Typhoid Fever Vaccines Market Revenue and Forecast to 2027 (USD Million)
Figure 34. Europe: Typhoid Fever Vaccines Market, by Country, 2018 & 2027 (%)
Figure 35. Germany: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
Figure 36. UK: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
Figure 37. France: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
Figure 38. Spain: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
Figure 39. Italy: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
Figure 40. Rest of Europe: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
Figure 41. Asia Pacific: Typhoid Fever Vaccines Market, by Key Country - Revenue (2019) (USD Million)
Figure 42. Asia Pacific Typhoid Fever Vaccines Market Revenue and Forecast to 2027 (USD Million)
Figure 43. China: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
Figure 44. Japan: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
Figure 45. India: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
Figure 46. South Korea: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
Figure 47. Australia: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
Figure 48. Rest of Asia-Pacific: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
Figure 49. Middle East and Africa: Typhoid Fever Vaccines Market, by Key Country - Revenue (2019) (USD Million)
Figure 50. Middle East and Africa: Typhoid Fever Vaccines Market, Revenue and Forecast to 2027 (USD Million)
Figure 51. Middle East & Africa: Typhoid Fever Vaccines Market, by Country, 2019 & 2027 (%)
Figure 52. Saudi Arabia: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
Figure 53. UAE: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
Figure 54. South Africa: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
Figure 55. Rest of MEA: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
Figure 56. South & Central America: Typhoid Fever Vaccines Market, by Key Country - Revenue (2019) (USD Million)
Figure 57. South & Central America: Typhoid Fever Vaccines Market, Revenue and Forecast to 2027 (USD Million)
Figure 58. South & Central America: Typhoid Fever Vaccines Market, by Country, 2019 & 2027 (%)
Figure 59. Brazil: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
Figure 60. Argentina: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
Figure 61. Rest of SCAM: Typhoid Fever Vaccines Market - Revenue and Forecast to 2027 (USD Million)
Figure 62. Impact of COVID-19 Pandemic on Typhoid Fever Vaccines market in North American Countries
Figure 63. Impact of COVID-19 Pandemic on Typhoid Fever Vaccines market in European Countries
Figure 64. Impact of COVID-19 Pandemic on Typhoid Fever Vaccines market in Asia Pacific Countries
Figure 65. Impact of COVID-19 Pandemic on Typhoid Fever Vaccines market in Rest of the World
Figure 66. Growth Strategies Done by the Companies in the Market, (%)

Note: Product cover images may vary from those shown
  • Shanghai institute of biological products co., ltd.
  • BHARAT BIOTECH
  • Sanofi
  • GlaxoSmithKline plc.
  • Paxvax Inc.
  • PT Bio Farma
  • BIO-MED
  • Prokarium Ltd.
  • Scandinavian Biopharma
Note: Product cover images may vary from those shown
Adroll
adroll